Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2022 Apr;25(4):e25902.
doi: 10.1002/jia2.25902.

Use of quality-of-life instruments for people living with HIV: a global systematic review and meta-analysis

Affiliations
Meta-Analysis

Use of quality-of-life instruments for people living with HIV: a global systematic review and meta-analysis

Ying Zhang et al. J Int AIDS Soc. 2022 Apr.

Abstract

Introduction: Due to the effectiveness of combined antiretroviral therapy and its growing availability worldwide, most people living with HIV (PLHIV) have a near-normal life expectancy. However, PLHIV continue to face various health and social challenges that severely impact their health-related quality-of-life (HRQoL). The UNAIDS Global AIDS Strategy discusses the need to optimize quality-of-life, but no guidance was given regarding which instruments were appropriate measures of HRQoL. This study aimed to review and assess the use of HRQoL instruments for PLHIV.

Methods: We conducted a global systematic review and meta-analysis, searching five databases for studies published between January 2010 and February 2021 that assessed HRQoL among PLHIV aged 16 years and over. Multivariable regression analyses were performed to identify factors associated with the choice of HRQoL instruments. We examined the domains covered by each instrument. Random-effects meta-analysis was conducted to explore the average completion rates of HRQoL instruments.

Results and discussion: From 714 publications, we identified 65 different HRQoL instruments. The most commonly used instruments were the World Health Organization Quality-of-Life- HIV Bref (WHOQOL-HIV BREF)-19%, Medical Outcome Survey-HIV (MOS-HIV)-17%, Short Form-36 (SF-36)-12%, European Quality-of-Life Instrument-5 Dimension (EQ-5D)-10%, World Health Organization Quality-of-Life Bref (WHOQOL BREF)-8%, Short Form-12 (SF-12)-7% and HIV/AIDS Targeted Quality-of-Life (HAT-QOL)-6%. There were greater odds of using HIV-specific instruments for middle- and low-income countries (than high-income countries), studies in the Americas and Europe (than Africa) and target population of PLHIV only (than both PLHIV and people without HIV). Domains unique to the HIV-specific instruments were worries about death, stigma and HIV disclosure. There were no significant differences in completion rates between different HRQoL instruments. The overall pooled completion rate was 95.9% (95% CI: 94.7-97.0, I2 = 99.2%, p < 0.01); some heterogeneity was explained by country-income level and study type.

Conclusions: A wide range of instruments have been used to assess HRQoL in PLHIV, and the choice of instrument might be based on their different characteristics and reason for application. Although completion rates were high, future studies should explore the feasibility of implementing these instruments and the appropriateness of domains covered by each instrument.

Keywords: HIV; HIV-specific instrument; PROSPERO Number: CRD42021240815; generic instrument; people living with HIV; quality of life; systematic review.

PubMed Disclaimer

Conflict of interest statement

ROA is an employee of Roche Products Ltd. The views expressed in this article are his own and do not represent that of his employers. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential competing interest.

JJO conceived the idea for this paper. YZ, CH and ESGH did the screening and data extraction. YZ and JJO conducted the statistical analysis. All authors had full access to all the data in the study, contributed to the interpretation and subsequent edits of the manuscript, and had final responsibility for the decision to submit for publication.

Figures

Figure 1
Figure 1
PRISMA flow diagram. This depicts the paper selection process.
Figure 2
Figure 2
The number of HRQoL instruments used over time.
Figure 3
Figure 3
Frequency distribution of the most commonly used HRQoL instrument.

References

    1. World Health Organization . Estimated number of people (all ages) living with HIV. Geneva: World Health Organisation; 2020.
    1. Brashers DE, Neidig JL, Goldsmith DJ. Social support and the management of uncertainty for people living with HIV or AIDS. Health Commun. 2004;. 16(3):305–31. - PubMed
    1. The Joint United Nations Programme on HIV/AIDS (UNAIDS) . 90–90–90: good progress, but the world is off‐track for hitting the 2020 targets. Geneva: UNAIDS; 2020.
    1. Drewes J, Gusy B, Ruden U. More than 20 years of research into the quality of life of people with HIV and AIDS: a descriptive review of study characteristics and methodological approaches of published empirical studies. J Int Assoc Provid AIDS Care. 2013;. 12(1):18–22. - PubMed
    1. Clayson DJ, Wild DJ, Quarterman P, Duprat‐Lomon I, Kubin M, Coons SJ. A comparative review of health‐related quality‐of‐life measures for use in HIV/AIDS clinical trials. Pharmacoeconomics. 2006;. 24(8):751–65. - PubMed

Publication types

MeSH terms

Substances